NPI: 1023060472 · FORT WAYNE, IN 46802 · General Acute Care Hospital · NPI assigned 05/16/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/16/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 55,282 | $1.00M |
| 2019 | 44,990 | $1.73M |
| 2020 | 37,007 | $1.61M |
| 2021 | 46,159 | $2.70M |
| 2022 | 105,495 | $6.87M |
| 2023 | 99,069 | $6.68M |
| 2024 | 62,880 | $4.83M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 46,226 | 38,790 | $7.79M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 34,364 | 27,231 | $5.85M |
| 71045 | Radiologic examination, chest; single view | 12,679 | 9,885 | $1.81M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,070 | 7,558 | $1.57M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 21,576 | 15,249 | $1.42M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11,212 | 8,952 | $769K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,988 | 5,196 | $704K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 266 | 236 | $655K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 923 | 670 | $391K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12,860 | 10,628 | $366K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,321 | 1,746 | $282K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,648 | 2,000 | $269K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 538 | 371 | $225K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,065 | 6,504 | $201K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 35,349 | 25,747 | $169K |
| 99217 | 431 | 326 | $161K | |
| 99218 | 443 | 336 | $158K | |
| 80053 | Comprehensive metabolic panel | 23,185 | 17,300 | $153K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 10,744 | 8,365 | $132K |
| 99221 | 366 | 258 | $126K | |
| 93017 | 872 | 626 | $126K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 160 | 99 | $123K |
| 36415 | Collection of venous blood by venipuncture | 55,917 | 40,020 | $123K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 76 | 54 | $120K |
| 99238 | Hospital discharge day management, 30 minutes or less | 388 | 271 | $119K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 108 | 69 | $119K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 330 | 246 | $118K |
| 71046 | Radiologic examination, chest; 2 views | 1,304 | 1,068 | $118K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,322 | 5,544 | $116K |
| 84484 | 15,471 | 8,729 | $108K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,137 | 1,597 | $87K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4,520 | 3,169 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,412 | 3,799 | $61K |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,598 | 8,593 | $56K |
| 80050 | General health panel | 338 | 314 | $50K |
| G0378 | Hospital observation service, per hour | 276 | 156 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,489 | 1,286 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,490 | 1,287 | $38K |
| 80061 | Lipid panel | 4,661 | 3,900 | $35K |
| 81001 | 16,125 | 12,631 | $31K | |
| 81025 | 4,765 | 3,796 | $30K | |
| 83690 | 8,435 | 6,279 | $30K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 116 | 88 | $28K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 203 | 176 | $27K |
| 87430 | 1,864 | 1,611 | $27K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 71 | 51 | $26K |
| 16020 | 158 | 95 | $21K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 755 | 675 | $18K |
| 83735 | 4,805 | 2,933 | $18K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 17 | 12 | $18K |
| J2785 | Injection, regadenoson, 0.1 mg | 407 | 290 | $17K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 375 | 318 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | 85 | 65 | $16K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,907 | 2,282 | $15K |
| 93246 | 55 | 41 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 210 | 174 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,515 | 2,081 | $14K |
| 85027 | 5,073 | 3,836 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,131 | 891 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 738 | 423 | $10K |
| 90870 | 275 | 113 | $10K | |
| 82947 | 5,096 | 3,028 | $9K | |
| 80076 | 2,653 | 2,079 | $9K | |
| 82077 | 670 | 500 | $8K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 283 | 207 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 412 | 373 | $7K |
| 87400 | 1,043 | 449 | $7K | |
| 83880 | 333 | 211 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 517 | 277 | $6K |
| 87807 | 464 | 417 | $6K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 28 | 25 | $5K |
| 93242 | 18 | 12 | $5K | |
| 84703 | 809 | 613 | $5K | |
| 80051 | 2,361 | 1,822 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 269 | 235 | $4K |
| 82565 | 2,364 | 1,825 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 166 | 129 | $3K |
| 84520 | 2,381 | 1,835 | $2K | |
| 87340 | 429 | 388 | $2K | |
| 81003 | 906 | 692 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 61 | 54 | $1K |
| 83605 | 210 | 119 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 230 | 124 | $1K |
| 85379 | 173 | 118 | $1K | |
| 85610 | 538 | 389 | $1K | |
| 86592 | 364 | 325 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 42 | 33 | $1K |
| 82248 | 285 | 219 | $963.85 | |
| 73630 | 37 | 25 | $792.78 | |
| 97161 | 21 | 13 | $745.84 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 85 | 73 | $660.03 |
| 82607 | 65 | 51 | $575.01 | |
| J3490 | Unclassified drugs | 28 | 26 | $474.18 |
| 87641 | 58 | 37 | $462.33 | |
| 82550 | 110 | 84 | $448.75 | |
| 87040 | 92 | 30 | $374.62 | |
| 84145 | 22 | 15 | $326.64 | |
| 84238 | 15 | 12 | $302.41 | |
| 88342 | 15 | 12 | $297.14 | |
| 82746 | 35 | 27 | $231.54 | |
| 84403 | 16 | 14 | $227.19 | |
| 82728 | 35 | 27 | $212.34 | |
| 85730 | 84 | 68 | $199.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,749 | 6,037 | $194.61 |
| 84439 | 44 | 38 | $193.85 | |
| 87077 | 33 | 25 | $185.84 | |
| 86803 | 16 | 13 | $165.27 | |
| 84702 | 16 | 14 | $159.76 | |
| 84100 | 53 | 28 | $137.46 | |
| 83550 | 34 | 26 | $127.73 | |
| 83540 | 34 | 26 | $94.58 | |
| 82043 | 43 | 30 | $85.35 | |
| 87210 | 31 | 26 | $84.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,810 | 2,130 | $80.59 |
| 96376 | 296 | 98 | $73.71 | |
| 81000 | 23 | 18 | $67.95 | |
| 84550 | 16 | 14 | $39.77 | |
| 86900 | 14 | 12 | $27.37 | |
| 86901 | 14 | 12 | $27.37 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 368 | 270 | $27.15 |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,508 | 2,164 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 102 | 81 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 17 | 17 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 13 | 13 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 13 | 12 | $0.00 |
| 90715 | 16 | 12 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 379 | 200 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 152 | 113 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 242 | 96 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 263 | 226 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 66 | 61 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 361 | 287 | $0.00 |
| A9270 | Non-covered item or service | 96 | 89 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 12 | 12 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 17 | 13 | $0.00 |